nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—ABCB1—peripheral nervous system neoplasm	0.423	1	CbGaD
Lamotrigine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.033	0.239	CbGbCtD
Lamotrigine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.033	0.239	CbGbCtD
Lamotrigine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0229	0.166	CbGbCtD
Lamotrigine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0141	0.102	CbGbCtD
Lamotrigine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0132	0.0953	CbGbCtD
Lamotrigine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0129	0.0937	CbGbCtD
Lamotrigine—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.012	0.393	CbGeAlD
Lamotrigine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00882	0.0639	CbGbCtD
Lamotrigine—SCN8A—nerve—peripheral nervous system neoplasm	0.00378	0.124	CbGeAlD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.00313	0.0645	CbGpPWpGaD
Lamotrigine—SCN10A—nerve—peripheral nervous system neoplasm	0.00253	0.083	CbGeAlD
Lamotrigine—SCN10A—ganglion—peripheral nervous system neoplasm	0.0025	0.082	CbGeAlD
Lamotrigine—SCN8A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00203	0.0418	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00164	0.0338	CbGpPWpGaD
Lamotrigine—SCN8A—brainstem—peripheral nervous system neoplasm	0.00162	0.0533	CbGeAlD
Lamotrigine—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.00161	0.0529	CbGeAlD
Lamotrigine—SCN3A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00157	0.0323	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00151	0.0311	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00151	0.0311	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00145	0.03	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00145	0.03	CbGpPWpGaD
Lamotrigine—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.00123	0.0403	CbGeAlD
Lamotrigine—SCN1A—brainstem—peripheral nervous system neoplasm	0.00123	0.0403	CbGeAlD
Lamotrigine—SCN2A—brainstem—peripheral nervous system neoplasm	0.00113	0.0369	CbGeAlD
Lamotrigine—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00102	0.0211	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.001	0.0206	CbGpPWpGaD
Lamotrigine—SCN8A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000991	0.0204	CbGpPWpGaD
Lamotrigine—UGT1A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000941	0.0194	CbGpPWpGaD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.000803	0.0165	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000801	0.0165	CbGpPWpGaD
Lamotrigine—SCN8A—cerebellum—peripheral nervous system neoplasm	0.0008	0.0263	CbGeAlD
Lamotrigine—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000782	0.0161	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000767	0.0158	CbGpPWpGaD
Lamotrigine—SCN3A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000766	0.0158	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000736	0.0152	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000736	0.0152	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00071	0.0146	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00071	0.0146	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00062	0.0128	CbGpPWpGaD
Lamotrigine—SCN1A—cerebellum—peripheral nervous system neoplasm	0.000605	0.0198	CbGeAlD
Lamotrigine—SCN3A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000593	0.0122	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00057	0.0117	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00057	0.0117	CbGpPWpGaD
Lamotrigine—SCN2A—cerebellum—peripheral nervous system neoplasm	0.000555	0.0182	CbGeAlD
Lamotrigine—SCN10A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000549	0.0113	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000549	0.0113	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000547	0.0113	CbGpPWpGaD
Lamotrigine—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000499	0.0103	CbGpPWpGaD
Lamotrigine—SCN3A—cerebellum—peripheral nervous system neoplasm	0.000488	0.016	CbGeAlD
Lamotrigine—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000442	0.00912	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000423	0.00872	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000407	0.00838	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000407	0.00838	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000392	0.00808	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000392	0.00808	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000386	0.00796	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000374	0.00772	CbGpPWpGaD
Lamotrigine—UGT1A4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000354	0.00729	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000303	0.00624	CbGpPWpGaD
Lamotrigine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000301	0.00987	CbGeAlD
Lamotrigine—UGT1A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000294	0.00606	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00029	0.00597	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000288	0.00593	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000278	0.00573	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000278	0.00573	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000276	0.00568	CbGpPWpGaD
Lamotrigine—UGT1A4—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000271	0.00559	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000268	0.00553	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000268	0.00553	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000267	0.00551	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000264	0.00544	CbGpPWpGaD
Lamotrigine—UGT1A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000225	0.00465	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000223	0.00459	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000216	0.00445	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000215	0.00443	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000207	0.00426	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000199	0.00409	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000199	0.00409	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000191	0.00395	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000191	0.00395	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000189	0.00389	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000185	0.00381	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—MET—peripheral nervous system neoplasm	0.000179	0.00369	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000176	0.00363	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000165	0.00341	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00015	0.0031	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000148	0.00304	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.000145	0.00298	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	0.000138	0.00285	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000135	0.00277	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000134	0.00276	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.000133	0.00274	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.000133	0.00274	CbGpPWpGaD
Lamotrigine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000131	0.00431	CbGeAlD
Lamotrigine—SCN8A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000131	0.0027	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000128	0.00264	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000128	0.00264	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000128	0.00264	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000128	0.00263	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000125	0.00258	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000123	0.00253	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000123	0.00253	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000119	0.00244	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000119	0.00244	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000118	0.00243	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GNS—peripheral nervous system neoplasm	0.000109	0.00224	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000107	0.00221	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000106	0.00218	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—NME1—peripheral nervous system neoplasm	0.000104	0.00215	CbGpPWpGaD
Lamotrigine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000287	CcSEcCtD
Lamotrigine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000287	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000103	0.00213	CbGpPWpGaD
Lamotrigine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000286	CcSEcCtD
Lamotrigine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000103	0.000286	CcSEcCtD
Lamotrigine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000285	CcSEcCtD
Lamotrigine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000103	0.000285	CcSEcCtD
Lamotrigine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000285	CcSEcCtD
Lamotrigine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000102	0.000284	CcSEcCtD
Lamotrigine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000283	CcSEcCtD
Lamotrigine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000282	CcSEcCtD
Lamotrigine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000282	CcSEcCtD
Lamotrigine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000282	CcSEcCtD
Lamotrigine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000101	0.000282	CcSEcCtD
Lamotrigine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000281	CcSEcCtD
Lamotrigine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000281	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000101	0.00209	CbGpPWpGaD
Lamotrigine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000279	CcSEcCtD
Lamotrigine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000101	0.000279	CcSEcCtD
Lamotrigine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.0001	0.000279	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—COX2—peripheral nervous system neoplasm	0.0001	0.00207	CbGpPWpGaD
Lamotrigine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000278	CcSEcCtD
Lamotrigine—Renal failure—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.000277	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.97e-05	0.000277	CcSEcCtD
Lamotrigine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.97e-05	0.000277	CcSEcCtD
Lamotrigine—Fatigue—Etoposide—peripheral nervous system neoplasm	9.96e-05	0.000276	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.95e-05	0.000276	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.95e-05	0.00205	CbGpPWpGaD
Lamotrigine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	9.9e-05	0.000275	CcSEcCtD
Lamotrigine—Constipation—Etoposide—peripheral nervous system neoplasm	9.88e-05	0.000274	CcSEcCtD
Lamotrigine—Pain—Etoposide—peripheral nervous system neoplasm	9.88e-05	0.000274	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	9.88e-05	0.00204	CbGpPWpGaD
Lamotrigine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000274	CcSEcCtD
Lamotrigine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000274	CcSEcCtD
Lamotrigine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000273	CcSEcCtD
Lamotrigine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000273	CcSEcCtD
Lamotrigine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.79e-05	0.000271	CcSEcCtD
Lamotrigine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.76e-05	0.000271	CcSEcCtD
Lamotrigine—Sweating—Epirubicin—peripheral nervous system neoplasm	9.73e-05	0.00027	CcSEcCtD
Lamotrigine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.00027	CcSEcCtD
Lamotrigine—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	9.72e-05	0.002	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	9.72e-05	0.002	CbGpPWpGaD
Lamotrigine—Haematuria—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000269	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.000267	CcSEcCtD
Lamotrigine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000266	CcSEcCtD
Lamotrigine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.58e-05	0.000266	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.55e-05	0.00197	CbGpPWpGaD
Lamotrigine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000264	CcSEcCtD
Lamotrigine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000264	CcSEcCtD
Lamotrigine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.52e-05	0.000264	CcSEcCtD
Lamotrigine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000264	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	9.49e-05	0.00196	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	9.49e-05	0.00196	CbGpPWpGaD
Lamotrigine—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.48e-05	0.000263	CcSEcCtD
Lamotrigine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000263	CcSEcCtD
Lamotrigine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000262	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.45e-05	0.000262	CcSEcCtD
Lamotrigine—Dizziness—Vincristine—peripheral nervous system neoplasm	9.43e-05	0.000262	CcSEcCtD
Lamotrigine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.41e-05	0.000261	CcSEcCtD
Lamotrigine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000261	CcSEcCtD
Lamotrigine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000261	CcSEcCtD
Lamotrigine—Infestation—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000261	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	9.37e-05	0.00193	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	9.37e-05	0.00193	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	9.33e-05	0.00192	CbGpPWpGaD
Lamotrigine—Rash—Alitretinoin—peripheral nervous system neoplasm	9.33e-05	0.000259	CcSEcCtD
Lamotrigine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.32e-05	0.000259	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.000258	CcSEcCtD
Lamotrigine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.29e-05	0.000258	CcSEcCtD
Lamotrigine—Headache—Alitretinoin—peripheral nervous system neoplasm	9.27e-05	0.000257	CcSEcCtD
Lamotrigine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000256	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.000255	CcSEcCtD
Lamotrigine—Urticaria—Etoposide—peripheral nervous system neoplasm	9.18e-05	0.000255	CcSEcCtD
Lamotrigine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000254	CcSEcCtD
Lamotrigine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.000254	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	9.15e-05	0.00189	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	9.15e-05	0.00189	CbGpPWpGaD
Lamotrigine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000253	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.13e-05	0.00188	CbGpPWpGaD
Lamotrigine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.13e-05	0.000253	CcSEcCtD
Lamotrigine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.13e-05	0.000253	CcSEcCtD
Lamotrigine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000253	CcSEcCtD
Lamotrigine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000253	CcSEcCtD
Lamotrigine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000253	CcSEcCtD
Lamotrigine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000253	CcSEcCtD
Lamotrigine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	9.07e-05	0.000252	CcSEcCtD
Lamotrigine—Vomiting—Vincristine—peripheral nervous system neoplasm	9.07e-05	0.000252	CcSEcCtD
Lamotrigine—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.05e-05	0.000251	CcSEcCtD
Lamotrigine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000251	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—GNS—peripheral nervous system neoplasm	9.03e-05	0.00186	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	9.01e-05	0.00186	CbGpPWpGaD
Lamotrigine—Sweating—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.00025	CcSEcCtD
Lamotrigine—Rash—Vincristine—peripheral nervous system neoplasm	8.99e-05	0.000249	CcSEcCtD
Lamotrigine—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.98e-05	0.000249	CcSEcCtD
Lamotrigine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000249	CcSEcCtD
Lamotrigine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000248	CcSEcCtD
Lamotrigine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000248	CcSEcCtD
Lamotrigine—Headache—Vincristine—peripheral nervous system neoplasm	8.93e-05	0.000248	CcSEcCtD
Lamotrigine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000246	CcSEcCtD
Lamotrigine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000245	CcSEcCtD
Lamotrigine—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.79e-05	0.000244	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	8.78e-05	0.00181	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	8.78e-05	0.00181	CbGpPWpGaD
Lamotrigine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000243	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—NME1—peripheral nervous system neoplasm	8.66e-05	0.00179	CbGpPWpGaD
Lamotrigine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.63e-05	0.000239	CcSEcCtD
Lamotrigine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000239	CcSEcCtD
Lamotrigine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000236	CcSEcCtD
Lamotrigine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.51e-05	0.000236	CcSEcCtD
Lamotrigine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000236	CcSEcCtD
Lamotrigine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000235	CcSEcCtD
Lamotrigine—Nausea—Vincristine—peripheral nervous system neoplasm	8.47e-05	0.000235	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	8.46e-05	0.00174	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	8.46e-05	0.00174	CbGpPWpGaD
Lamotrigine—Flushing—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000235	CcSEcCtD
Lamotrigine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000235	CcSEcCtD
Lamotrigine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000234	CcSEcCtD
Lamotrigine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000234	CcSEcCtD
Lamotrigine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.39e-05	0.000233	CcSEcCtD
Lamotrigine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000232	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—COX2—peripheral nervous system neoplasm	8.34e-05	0.00172	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	8.34e-05	0.00172	CbGpPWpGaD
Lamotrigine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.00023	CcSEcCtD
Lamotrigine—Asthenia—Etoposide—peripheral nervous system neoplasm	8.29e-05	0.00023	CcSEcCtD
Lamotrigine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.00023	CcSEcCtD
Lamotrigine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000229	CcSEcCtD
Lamotrigine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	8.21e-05	0.000228	CcSEcCtD
Lamotrigine—Chills—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000227	CcSEcCtD
Lamotrigine—Pruritus—Etoposide—peripheral nervous system neoplasm	8.17e-05	0.000227	CcSEcCtD
Lamotrigine—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.05e-05	0.000223	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	8.05e-05	0.00166	CbGpPWpGaD
Lamotrigine—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.02e-05	0.000222	CcSEcCtD
Lamotrigine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000222	CcSEcCtD
Lamotrigine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000221	CcSEcCtD
Lamotrigine—Rash—Cisplatin—peripheral nervous system neoplasm	7.95e-05	0.000221	CcSEcCtD
Lamotrigine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.94e-05	0.00022	CcSEcCtD
Lamotrigine—Erythema—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.00022	CcSEcCtD
Lamotrigine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.00022	CcSEcCtD
Lamotrigine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.9e-05	0.000219	CcSEcCtD
Lamotrigine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000219	CcSEcCtD
Lamotrigine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000218	CcSEcCtD
Lamotrigine—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000217	CcSEcCtD
Lamotrigine—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000217	CcSEcCtD
Lamotrigine—Tension—Epirubicin—peripheral nervous system neoplasm	7.79e-05	0.000216	CcSEcCtD
Lamotrigine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.77e-05	0.000216	CcSEcCtD
Lamotrigine—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000214	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	7.7e-05	0.00159	CbGpPWpGaD
Lamotrigine—Back pain—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.000213	CcSEcCtD
Lamotrigine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000212	CcSEcCtD
Lamotrigine—Dizziness—Etoposide—peripheral nervous system neoplasm	7.64e-05	0.000212	CcSEcCtD
Lamotrigine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000212	CcSEcCtD
Lamotrigine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000211	CcSEcCtD
Lamotrigine—Chills—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.00021	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.55e-05	0.00156	CbGpPWpGaD
Lamotrigine—Nausea—Cisplatin—peripheral nervous system neoplasm	7.49e-05	0.000208	CcSEcCtD
Lamotrigine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000207	CcSEcCtD
Lamotrigine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.45e-05	0.000207	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	7.39e-05	0.00152	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	7.39e-05	0.00152	CbGpPWpGaD
Lamotrigine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000205	CcSEcCtD
Lamotrigine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000204	CcSEcCtD
Lamotrigine—Vomiting—Etoposide—peripheral nervous system neoplasm	7.35e-05	0.000204	CcSEcCtD
Lamotrigine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000204	CcSEcCtD
Lamotrigine—Erythema—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000204	CcSEcCtD
Lamotrigine—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.000203	CcSEcCtD
Lamotrigine—Agitation—Epirubicin—peripheral nervous system neoplasm	7.29e-05	0.000202	CcSEcCtD
Lamotrigine—Rash—Etoposide—peripheral nervous system neoplasm	7.28e-05	0.000202	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—HRAS—peripheral nervous system neoplasm	7.28e-05	0.0015	CbGpPWpGaD
Lamotrigine—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.28e-05	0.000202	CcSEcCtD
Lamotrigine—Headache—Etoposide—peripheral nervous system neoplasm	7.24e-05	0.000201	CcSEcCtD
Lamotrigine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000201	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.23e-05	0.00149	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.22e-05	0.00149	CbGpPWpGaD
Lamotrigine—Tension—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.0002	CcSEcCtD
Lamotrigine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.19e-05	0.000199	CcSEcCtD
Lamotrigine—Malaise—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000198	CcSEcCtD
Lamotrigine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000198	CcSEcCtD
Lamotrigine—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	7.13e-05	0.00147	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	7.13e-05	0.00147	CbGpPWpGaD
Lamotrigine—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000198	CcSEcCtD
Lamotrigine—Syncope—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000197	CcSEcCtD
Lamotrigine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000197	CcSEcCtD
Lamotrigine—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000197	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.1e-05	0.00146	CbGpPWpGaD
Lamotrigine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000196	CcSEcCtD
Lamotrigine—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.01e-05	0.000195	CcSEcCtD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	6.99e-05	0.00144	CbGpPWpGaD
Lamotrigine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000193	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.94e-05	0.00143	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.94e-05	0.00143	CbGpPWpGaD
Lamotrigine—Cough—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000192	CcSEcCtD
Lamotrigine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000192	CcSEcCtD
Lamotrigine—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000191	CcSEcCtD
Lamotrigine—Nausea—Etoposide—peripheral nervous system neoplasm	6.86e-05	0.00019	CcSEcCtD
Lamotrigine—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.00019	CcSEcCtD
Lamotrigine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000189	CcSEcCtD
Lamotrigine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000188	CcSEcCtD
Lamotrigine—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000187	CcSEcCtD
Lamotrigine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000187	CcSEcCtD
Lamotrigine—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000187	CcSEcCtD
Lamotrigine—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000187	CcSEcCtD
Lamotrigine—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000187	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.69e-05	0.00138	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.69e-05	0.00138	CbGpPWpGaD
Lamotrigine—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000185	CcSEcCtD
Lamotrigine—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000184	CcSEcCtD
Lamotrigine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000183	CcSEcCtD
Lamotrigine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000183	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	6.59e-05	0.00136	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	6.59e-05	0.00136	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ENO2—peripheral nervous system neoplasm	6.58e-05	0.00136	CbGpPWpGaD
Lamotrigine—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000183	CcSEcCtD
Lamotrigine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000182	CcSEcCtD
Lamotrigine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000181	CcSEcCtD
Lamotrigine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.00018	CcSEcCtD
Lamotrigine—Oedema—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.00018	CcSEcCtD
Lamotrigine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000179	CcSEcCtD
Lamotrigine—Infection—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000178	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	6.43e-05	0.00133	CbGpPWpGaD
Lamotrigine—Cough—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000178	CcSEcCtD
Lamotrigine—Shock—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000177	CcSEcCtD
Lamotrigine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000176	CcSEcCtD
Lamotrigine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000176	CcSEcCtD
Lamotrigine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000176	CcSEcCtD
Lamotrigine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000176	CcSEcCtD
Lamotrigine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000175	CcSEcCtD
Lamotrigine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000174	CcSEcCtD
Lamotrigine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000173	CcSEcCtD
Lamotrigine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000173	CcSEcCtD
Lamotrigine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000173	CcSEcCtD
Lamotrigine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000173	CcSEcCtD
Lamotrigine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000171	CcSEcCtD
Lamotrigine—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000171	CcSEcCtD
Lamotrigine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.00017	CcSEcCtD
Lamotrigine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	6.11e-05	0.00126	CbGpPWpGaD
Lamotrigine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000168	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	6.04e-05	0.00124	CbGpPWpGaD
Lamotrigine—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000166	CcSEcCtD
Lamotrigine—Infection—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000165	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	5.95e-05	0.00123	CbGpPWpGaD
Lamotrigine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000164	CcSEcCtD
Lamotrigine—Shock—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000164	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.89e-05	0.00121	CbGpPWpGaD
Lamotrigine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000163	CcSEcCtD
Lamotrigine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000163	CcSEcCtD
Lamotrigine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.86e-05	0.00121	CbGpPWpGaD
Lamotrigine—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000162	CcSEcCtD
Lamotrigine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000162	CcSEcCtD
Lamotrigine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000161	CcSEcCtD
Lamotrigine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000161	CcSEcCtD
Lamotrigine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.00016	CcSEcCtD
Lamotrigine—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.00016	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.74e-05	0.00118	CbGpPWpGaD
Lamotrigine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000158	CcSEcCtD
Lamotrigine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000158	CcSEcCtD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.64e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.63e-05	0.00116	CbGpPWpGaD
Lamotrigine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000156	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000155	CcSEcCtD
Lamotrigine—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000155	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.56e-05	0.00115	CbGpPWpGaD
Lamotrigine—Pain—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000154	CcSEcCtD
Lamotrigine—Constipation—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000154	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.49e-05	0.00113	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	5.47e-05	0.00113	CbGpPWpGaD
Lamotrigine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000151	CcSEcCtD
Lamotrigine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.00015	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.41e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.41e-05	0.00111	CbGpPWpGaD
Lamotrigine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000149	CcSEcCtD
Lamotrigine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000148	CcSEcCtD
Lamotrigine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000148	CcSEcCtD
Lamotrigine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000148	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.31e-05	0.00109	CbGpPWpGaD
Lamotrigine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000147	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.28e-05	0.00109	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.28e-05	0.00109	CbGpPWpGaD
Lamotrigine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000146	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—TH—peripheral nervous system neoplasm	5.23e-05	0.00108	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.22e-05	0.00108	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.22e-05	0.00108	CbGpPWpGaD
Lamotrigine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000144	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.19e-05	0.00107	CbGpPWpGaD
Lamotrigine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000144	CcSEcCtD
Lamotrigine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000143	CcSEcCtD
Lamotrigine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.14e-05	0.000143	CcSEcCtD
Lamotrigine—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000142	CcSEcCtD
Lamotrigine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000142	CcSEcCtD
Lamotrigine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000142	CcSEcCtD
Lamotrigine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000142	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.09e-05	0.00105	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.09e-05	0.00105	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	5.01e-05	0.00103	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000137	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000136	CcSEcCtD
Lamotrigine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000132	CcSEcCtD
Lamotrigine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000132	CcSEcCtD
Lamotrigine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000131	CcSEcCtD
Lamotrigine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000131	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	4.7e-05	0.000969	CbGpPWpGaD
Lamotrigine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000129	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	4.62e-05	0.000953	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.59e-05	0.000945	CbGpPWpGaD
Lamotrigine—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000127	CcSEcCtD
Lamotrigine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000123	CcSEcCtD
Lamotrigine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000122	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.41e-05	0.000909	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	4.35e-05	0.000896	CbGpPWpGaD
Lamotrigine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000119	CcSEcCtD
Lamotrigine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000119	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.27e-05	0.00088	CbGpPWpGaD
Lamotrigine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000118	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.2e-05	0.000866	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.19e-05	0.000864	CbGpPWpGaD
Lamotrigine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000114	CcSEcCtD
Lamotrigine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000114	CcSEcCtD
Lamotrigine—Rash—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000113	CcSEcCtD
Lamotrigine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000113	CcSEcCtD
Lamotrigine—Headache—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000113	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.02e-05	0.000828	CbGpPWpGaD
Lamotrigine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.00011	CcSEcCtD
Lamotrigine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.96e-05	0.000816	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.86e-05	0.000796	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.86e-05	0.000796	CbGpPWpGaD
Lamotrigine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000107	CcSEcCtD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.82e-05	0.000788	CbGpPWpGaD
Lamotrigine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000106	CcSEcCtD
Lamotrigine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000105	CcSEcCtD
Lamotrigine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000105	CcSEcCtD
Lamotrigine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000104	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.72e-05	0.000767	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.72e-05	0.000767	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.71e-05	0.000764	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	3.67e-05	0.000756	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	3.58e-05	0.000737	CbGpPWpGaD
Lamotrigine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	9.87e-05	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	3.55e-05	0.000732	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.55e-05	0.000731	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.48e-05	0.000718	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.41e-05	0.000703	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.41e-05	0.000703	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.32e-05	0.000685	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.29e-05	0.000677	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.29e-05	0.000677	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.02e-05	0.000622	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.99e-05	0.000615	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.86e-05	0.00059	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.75e-05	0.000566	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.64e-05	0.000545	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.62e-05	0.000539	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.4e-05	0.000495	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.35e-05	0.000485	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.31e-05	0.000476	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.93e-05	0.000399	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.73e-05	0.000358	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.63e-05	0.000337	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.000302	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000288	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.000284	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-05	0.000238	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000232	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	9.58e-06	0.000197	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-06	6.26e-05	CbGpPWpGaD
